Cargando…
The presence of genetic risk variants within PTPN2 and PTPN22 is associated with intestinal microbiota alterations in Swiss IBD cohort patients
BACKGROUND: Genetic risk factors, intestinal microbiota and a dysregulated immune system contribute to the pathogenesis of inflammatory bowel disease (IBD). We have previously demonstrated that dysfunction of protein tyrosine phosphatase non-receptor type 2 (PTPN2) and PTPN22 contributes to alterati...
Autores principales: | Yilmaz, Bahtiyar, Spalinger, Marianne R., Biedermann, Luc, Franc, Yannick, Fournier, Nicolas, Rossel, Jean-Benoit, Juillerat, Pascal, Rogler, Gerhard, Macpherson, Andrew J., Scharl, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6028086/ https://www.ncbi.nlm.nih.gov/pubmed/29965986 http://dx.doi.org/10.1371/journal.pone.0199664 |
Ejemplares similares
-
Modulation of the Mucosa-Associated Microbiome Linked to the PTPN2 Risk Gene in Patients with Primary Sclerosing Cholangitis and Ulcerative Colitis
por: Denoth, Luisa, et al.
Publicado: (2021) -
PTPN22 regulates NLRP3-mediated IL1B secretion in an autophagy-dependent manner
por: Spalinger, Marianne R., et al.
Publicado: (2017) -
Genotype-Phenotype Associations of the CD-Associated Single Nucleotide Polymorphism within the Gene Locus Encoding Protein Tyrosine Phosphatase Non-Receptor Type 22 in Patients of the Swiss IBD Cohort
por: Spalinger, Marianne R., et al.
Publicado: (2016) -
PTPN2 as a promoter of colon carcinoma via reduction of inflammasome activation
por: Spalinger, Marianne R., et al.
Publicado: (2018) -
NLRP3 tyrosine phosphorylation is controlled by protein tyrosine phosphatase PTPN22
por: Spalinger, Marianne R., et al.
Publicado: (2023)